<DOC>
	<DOCNO>NCT00453960</DOCNO>
	<brief_summary>The aim study verify anti-estrogenic activity Genistein , `` non atypical endometrial hyperplasia '' , premenopausal woman .</brief_summary>
	<brief_title>Genistein Endometrial Hyperplasia</brief_title>
	<detailed_description>Although isoflavones alone ( example : Genistein ) weak estrogenic effect endometrial stromal glandular cell , demonstrate , several research effort , presence E2 act antiestrogens . Considered endometrial hyperplasia due strong extend estrogenic stimulation , offset proportionate amount progesterone , suppose genistein could therapeutic case induce decrease hyperplasia change proliferative secretory phase endometrium .</detailed_description>
	<mesh_term>Hyperplasia</mesh_term>
	<mesh_term>Endometrial Hyperplasia</mesh_term>
	<mesh_term>Norethindrone acetate</mesh_term>
	<mesh_term>Norethindrone</mesh_term>
	<mesh_term>Genistein</mesh_term>
	<criteria>Premenopausal woman Age &gt; = 44 year Dysfunctional uterine bleed No treatment hormonal drug ( estrogen , progesterone ) No local general pathology negatively influenced administration genistein progesterone No intrauterine pathology ( polyp , myoma ) A `` non atypical endometrial hyperplasia '' , confirm hysteroscopy biopsy histological examination All condition</criteria>
	<gender>Female</gender>
	<minimum_age>44 Years</minimum_age>
	<maximum_age>55 Years</maximum_age>
	<verification_date>December 2008</verification_date>
	<keyword>Endometrial hyperplasia</keyword>
	<keyword>Genistein</keyword>
	<keyword>Isoflavones</keyword>
	<keyword>dysfunctional uterine bleeding</keyword>
</DOC>